Pharmacological rescue of trafficking-impaired ATP-sensitive potassium channels

Frontiers in Physiology

Volumn 4 DEC, Issue , 2013, Pages

  Martin, Gregory M ^a   Chen, Pei Chun ^a   Devaraneni, Prasanna ^a   Shyng, Show Ling ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

ATP sensitive potassium channel; Carbamazepine; Congenital hyperinsulinism (CHI); Pharmacological chaperone; Sulfonylurea

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CARBAMAZEPINE; CHAPERONE; DIAZOXIDE; GLIBENCLAMIDE; GLIMEPIRIDE; REPAGLINIDE; SULFONYLUREA; SULFONYLUREA RECEPTOR; SULFONYLUREA RECEPTOR 1; TOLBUTAMIDE;

ANTIDIABETIC ACTIVITY; BIOGENESIS; CYSTIC FIBROSIS; DIABETES INSIPIDUS; DIABETES MELLITUS; DRUG BINDING SITE; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; DRUG STRUCTURE; ENDOPLASMIC RETICULUM; FAMILIAL HYPERCHOLESTEROLEMIA; HUMAN; MOLECULAR MECHANICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; RETINITIS PIGMENTOSA; REVIEW; STRUCTURE ANALYSIS;

EID: 84891713349     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2013.00386     Document Type: Review

References (142)

1. Aguilar-Bryan, L., and Bryan, J. (1999). Molecular biology of adenosine triphosphate-sensitive potassium channels. Endocr. Rev. 20, 101-135. doi: 10.1210/er.20.2.101.
2. Aguilar-Bryan, L., Clement, J. P. T., Gonzalez, G., Kunjilwar, K., Babenko, A., and Bryan, J. (1998). Toward understanding the assembly and structure of KATP channels. Physiol. Rev. 78, 227-245.
3. Aguilar-Bryan, L., Nelson, D. A., Vu, Q. A., Humphrey, M. B., and Boyd, A. E. 3rd. (1990). Photoaffinity labeling and partial purification of the beta cell sulfonylurea receptor using a novel, biologically active glyburide analog. J. Biol. Chem. 265, 8218-8224.
4. Aguilar-Bryan, L., Nichols, C. G., Wechsler, S. W., Clement, J. P. T., Boyd, A. E. 3rd., Gonzalez, G., et al. (1995). Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science 268, 423-426. doi: 10.1126/science.7716547.
5. Alekseev, A. E., Kennedy, M. E., Navarro, B., and Terzic, A. (1997). Burst kinetics of co-expressed Kir6.2/SUR1 clones: comparison of recombinant with native ATP-sensitive K+ channel behavior. J. Membr. Biol. 159, 161-168. doi: 10.1007/s002329900279.
6. Ambrosio, A. F., Soares-Da-Silva, P., Carvalho, C. M., and Carvalho, A. P. (2002). Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024. Neurochem. Res. 27, 121-130. doi: 10.1023/A:1014814924965.
7. Antcliff, J. F., Haider, S., Proks, P., Sansom, M. S., and Ashcroft, F. M. (2005). Functional analysis of a structural model of the ATP-binding site of the KATP channel Kir6.2 subunit. EMBO J. 24, 229-239. doi: 10.1038/sj.emboj.7600487.
8. Ashcroft, F. M. (2005). ATP-sensitive potassium channelopathies: focus on insulin secretion. J. Clin. Invest. 115, 2047-2058. doi: 10.1172/JCI25495.
9. Ashfield, R., Gribble, F. M., Ashcroft, S. J., and Ashcroft, F. M. (1999). Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K(ATP) channel. Diabetes 48, 1341-1347. doi: 10.2337/diabetes.48.6.1341.
10. Babenko, A. P. (2005). K(ATP) channels "vingt ans apres": ATG to PDB to Mechanism. J. Mol. Cell. Cardiol. 39, 79-98. doi: 10.1016/j.yjmcc.2004.12.004.
11. Babenko, A. P., and Bryan, J. (2003). SUR domains that associate with and gate KATP pores define a novel gatekeeper. J. Biol. Chem. 278, 41577. doi: 10.1074/jbc.C300363200.
12. Babenko, A. P., Gonzalez, G., and Bryan, J. (1999). Two regions of sulfonylurea receptor specify the spontaneous bursting and ATP inhibition of KATP channel isoforms. J. Biol. Chem. 274, 11587-11592. doi: 10.1074/jbc.274.17.11587.
13. Baukrowitz, T., Schulte, U., Oliver, D., Herlitze, S., Krauter, T., Tucker, S. J., et al. (1998). PIP2 and PIP as determinants for ATP inhibition of KATP channels. Science 282, 1141-1144. doi: 10.1126/science.282.5391.1141.
14. Branstrom, R., Leibiger, I. B., Leibiger, B., Corkey, B. E., Berggren, P. O., and Larsson, O. (1998). Long chain coenzyme A esters activate the pore-forming subunit (Kir6. 2) of the ATP-regulated potassium channel. J. Biol. Chem. 273, 31395-31400. doi: 10.1074/jbc.273.47.31395.
15. Brown, C. R., Hong-Brown, L. Q., Biwersi, J., Verkman, A. S., and Welch, W. J. (1996). Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein. Cell Stress Chaperones 1, 117-125.doi: 10.1379/1466-1268(1996)001<0117:CCCTMP>2.3.CO;2.
16. Brown, G. R., and Foubister, A. J. (1984). Receptor binding sites of hypoglycemic sulfonylureas and related [(acylamino)alkyl]benzoic acids. J. Med. Chem. 27, 79-81. doi: 10.1021/jm00367a016.
17. Bryan, J., Vila-Carriles, W. H., Zhao, G., Babenko, A. P., and Aguilar-Bryan, L. (2004). Toward linking structure with function in ATP-sensitive K+ channels. Diabetes 53(Suppl. 3), S104-S112. doi: 10.2337/diabetes.53.suppl_3.S104.
18. Capener, C. E., Shrivastava, I. H., Ranatunga, K. M., Forrest, L. R., Smith, G. R., and Sansom, M. S. (2000). Homology modeling and molecular dynamics simulation studies of an inward rectifier potassium channel. Biophys. J. 78, 2929-2942. doi: 10.1016/S0006-3495(00)76833-0.
19. Carlile, G. W., Robert, R., Zhang, D., Teske, K. A., Luo, Y., Hanrahan, J. W., et al. (2007). Correctors of protein trafficking defects identified by a novel high-throughput screening assay. Chembiochem 8, 1012-1020. doi: 10.1002/cbic.200700027.
20. Cartier, E. A., Conti, L. R., Vandenberg, C. A., and Shyng, S. L. (2001). Defective trafficking and function of KATP channels caused by a sulfonylurea receptor 1 mutation associated with persistent hyperinsulinemic hypoglycemia of infancy. Proc. Natl. Acad. Sci. U.S.A. 98, 2882-2887. doi: 10.1073/pnas.051499698.
21. Chan, K. W., Zhang, H., and Logothetis, D. E. (2003). N-terminal transmembrane domain of the SUR controls trafficking and gating of Kir6 channel subunits. EMBO J. 22, 3833-3843. doi: 10.1093/emboj/cdg376.
22. Chen, P. C., Bruederle, C. E., Gaisano, H. Y., and Shyng, S. L. (2011). Syntaxin 1A regulates surface expression of beta-cell ATP-sensitive potassium channels. Am. J. Physiol. Cell Physiol. 300, C506-C516. doi: 10.1152/ajpcell.00429.2010.
23. Chen, P. C., Kryukova, Y. N., and Shyng, S. L. (2013a). Leptin regulates KATP channel trafficking in pancreatic beta-cells by a signaling mechanism involving AMPK and PKA. J. Biol. Chem. 288, 34098-34109. doi: 10.1074/jbc.M113.516880.
24. Chen, P. C., Olson, E. M., Zhou, Q., Kryukova, Y., Sampson, H. M., Thomas, D. Y., et al. (2013b). Carbamazepine as a novel small molecule corrector of trafficking-impaired ATP-sensitive potassium channels identified in congenital hyperinsulinism. J. Biol. Chem. 288, 20942-20954. doi: 10.1074/jbc.M113.470948.
25. Cheng, S. H., Gregory, R. J., Marshall, J., Paul, S., Souza, D. W., White, G. A., et al. (1990). Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63, 827-834. doi: 10.1016/0092-8674(90)90148-8.
26. Clement, J. P. T., Kunjilwar, K., Gonzalez, G., Schwanstecher, M., Panten, U., Aguilar-Bryan, L., et al. (1997). Association and stoichiometry of K(ATP) channel subunits. Neuron 18, 827-838. doi: 10.1016/S0896-6273(00)80321-9.
27. Conti, L. R., Radeke, C. M., Shyng, S. L., and Vandenberg, C. A. (2001). Transmembrane topology of the sulfonylurea receptor SUR1. J. Biol. Chem. 276, 41270-41278. doi: 10.1074/jbc.M106555200.
28. Conti, L. R., Radeke, C. M., and Vandenberg, C. A. (2002). Membrane targeting of ATP-sensitive potassium channel. Effects of glycosylation on surface expression. J. Biol. Chem. 277, 25416-25422. doi: 10.1074/jbc.M203109200.
29. Crane, A., and Aguilar-Bryan, L. (2004). Assembly, maturation, and turnover of K(ATP) channel subunits. J. Biol. Chem. 279, 9080-9090. doi: 10.1074/jbc.M311079200.
30. Cukras, C. A., Jeliazkova, I., and Nichols, C. G. (2002a). The role of NH2-terminal positive charges in the activity of inward rectifier KATP channels. J. Gen. Physiol. 120, 437-446. doi: 10.1085/jgp.20028621.
31. Cukras, C. A., Jeliazkova, I., and Nichols, C. G. (2002b). Structural and functional determinants of conserved lipid interaction domains of inward rectifying Kir6.2 channels. J. Gen. Physiol. 119, 581-591. doi: 10.1085/jgp.20028562.
32. Denning, G. M., Anderson, M. P., Amara, J. F., Marshall, J., Smith, A. E., and Welsh, M. J. (1992). Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358, 761-764. doi: 10.1038/358761a0.
33. Detimary, P., Dejonghe, S., Ling, Z., Pipeleers, D., Schuit, F., and Henquin, J. C. (1998). The changes in adenine nucleotides measured in glucose-stimulated rodent islets occur in beta cells but not in alpha cells and are also observed in human islets. J. Biol. Chem. 273, 33905-33908. doi: 10.1074/jbc.273.51.33905.
34. De Wet, H., Mikhailov, M. V., Fotinou, C., Dreger, M., Craig, T. J., Venien-Bryan, C., et al. (2007). Studies of the ATPase activity of the ABC protein SUR1. FEBS J. 274, 3532-3544. doi: 10.1111/j.1742-4658.2007.05879.x.
35. Drain, P., Geng, X., and Li, L. (2004). Concerted gating mechanism underlying KATP channel inhibition by ATP. Biophys. J. 86, 2101-2112. doi: 10.1016/S0006-3495(04)74269-1.
36. Drumm, M. L., Wilkinson, D. J., Smit, L. S., Worrell, R. T., Strong, T. V., Frizzell, R. A., et al. (1991). Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes. Science 254, 1797-1799. doi: 10.1126/science.1722350.
37. Dunne, M. J., Yule, D. I., Gallacher, D. V., and Petersen, O. H. (1989). Cromakalim (BRL 34915) and diazoxide activate ATP-regulated potassium channels in insulin-secreting cells. Pflugers Arch. 414(Suppl. 1), S154-S155. doi: 10.1007/BF00582279.
38. Faletra, F., Snider, K., Shyng, S. L., Bruno, I., Athanasakis, E., Gasparini, P., et al. (2013). Co-inheritance of two ABCC8 mutations causing an unresponsive congenital hyperinsulinism: clinical and functional characterization of two novel ABCC8 mutations. Gene 516, 122-125. doi: 10.1016/j.gene.2012.12.055.
39. Fan, J. Q., Ishii, S., Asano, N., and Suzuki, Y. (1999). Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor. Nat. Med. 5, 112-115. doi: 10.1038/4801.
40. Fukuda, Y., Aguilar-Bryan, L., Vaxillaire, M., Dechaume, A., Wang, Y., Dean, M., et al. (2011). Conserved intramolecular disulfide bond is critical to trafficking and fate of ATP-binding cassette (ABC) transporters ABCB6 and sulfonylurea receptor 1 (SUR1)/ABCC8. J. Biol. Chem. 286, 8481-8492. doi: 10.1074/jbc.M110.174516.
41. Giblin, J. P., Leaney, J. L., and Tinker, A. (1999). The molecular assembly of ATP-sensitive potassium channels. Determinants on the pore forming subunit. J. Biol. Chem. 274, 22652-22659. doi: 10.1074/jbc.274.32.22652.
42. Giblin, J. P., Quinn, K., and Tinker, A. (2002). The cytoplasmic C-terminus of the sulfonylurea receptor is important for KATP channel function but is not key for complex assembly or trafficking. Eur. J. Biochem. 269, 5303-5313. doi: 10.1046/j.1432-1033.2002.03249.x.
43. Gloyn, A. L., Pearson, E. R., Antcliff, J. F., Proks, P., Bruining, G. J., Slingerland, A. S., et al. (2004). Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N. Engl. J. Med. 350, 1838-1849. doi: 10.1056/NEJMoa032922.
44. Gribble, F. M., and Reimann, F. (2003a). Differential selectivity of insulin secretagogues: mechanisms, clinical implications, and drug interactions. J. Diabetes Complications 17, 11-15. doi: 10.1016/S1056-8727(02)00272-6.
45. Gribble, F. M., and Reimann, F. (2003b). Sulphonylurea action revisited: the post-cloning era. Diabetologia 46, 875-891. doi: 10.1007/s00125-003-1143-3.
46. Gribble, F. M., Tucker, S. J., and Ashcroft, F. M. (1997). The essential role of the Walker A motifs of SUR1 in K-ATP channel activation by Mg-ADP and diazoxide. EMBO J. 16, 1145-1152. doi: 10.1093/emboj/16.6.1145.
47. Hanrahan, J. W., Sampson, H. M., and Thomas, D. Y. (2013). Novel pharmacological strategies to treat cystic fibrosis. Trends Pharmacol. Sci. 34, 119-125. doi: 10.1016/j.tips.2012.11.006.
48. Hattersley, A. T., and Ashcroft, F. M. (2005). Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy. Diabetes 54, 2503-2513. doi: 10.2337/diabetes.54.9.2503.
49. Heusser, K., Yuan, H., Neagoe, I., Tarasov, A. I., Ashcroft, F. M., and Schwappach, B. (2006). Scavenging of 14-3-3 proteins reveals their involvement in the cell-surface transport of ATP-sensitive K+ channels. J. Cell Sci. 119, 4353-4363. doi: 10.1242/jcs.03196.
50. Hidvegi, T., Ewing, M., Hale, P., Dippold, C., Beckett, C., Kemp, C., et al. (2010). An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis. Science 329, 229-232. doi: 10.1126/science.1190354.
51. Inagaki, N., Gonoi, T., Clement, J. P. T., Namba, N., Inazawa, J., Gonzalez, G., et al. (1995). Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor. Science 270, 1166-1170. doi: 10.1126/science.270.5239.1166.
52. Inagaki, N., Gonoi, T., and Seino, S. (1997). Subunit stoichiometry of the pancreatic beta-cell ATP-sensitive K+ channel. FEBS Lett. 409, 232-236. doi: 10.1016/S0014-5793(97)00488-2.
53. Jensen, T. J., Loo, M. A., Pind, S., Williams, D. B., Goldberg, A. L., and Riordan, J. R. (1995). Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell 83, 129-135. doi: 10.1016/0092-8674(95)90241-4.
54. Koster, J. C., Remedi, M. S., Dao, C., and Nichols, C. G. (2005). ATP and sulfonylurea sensitivity of mutant ATP-sensitive K+ channels in neonatal diabetes: implications for pharmacogenomic therapy. Diabetes 54, 2645-2654. doi: 10.2337/diabetes.54.9.2645.
55. Koster, J. C., Sha, Q., and Nichols, C. G. (1999). Sulfonylurea and K(+)-channel opener sensitivity of K(ATP) channels. Functional coupling of Kir6.2 and SUR1 subunits. J. Gen. Physiol. 114, 203-213. doi: 10.1085/jgp.114.2.203.
56. Kramer, W., Oekonomopulos, R., Punter, J., and Summ, H. D. (1988). Direct photoaffinity labeling of the putative sulfonylurea receptor in rat beta-cell tumor membranes by [3H]glibenclamide. FEBS Lett. 229, 355-359. doi: 10.1016/0014-5793(88)81155-4.
57. Larsson, O., Deeney, J. T., Branstrom, R., Berggren, P. O., and Corkey, B. E. (1996). Activation of the ATP-sensitive K+ channel by long chain acyl-CoA. A role in modulation of pancreatic beta-cell glucose sensitivity. J. Biol. Chem. 271, 10623-10626. doi: 10.1074/jbc.271.18.10623.
58. Li, J. B., Huang, X., Zhang, R. S., Kim, R. Y., Yang, R., and Kurata, H. T. (2013). Decomposition of slide helix contributions to ATP-dependent inhibition of Kir6.2 channels. J. Biol. Chem. 288, 23038-23049. doi: 10.1074/jbc.M113.485789.
59. Lilley, B. N., and Ploegh, H. L. (2004). A membrane protein required for dislocation of misfolded proteins from the ER. Nature 429, 834-840. doi: 10.1038/nature02592.
60. Lin, C. W., Lin, Y. W., Yan, F. F., Casey, J., Kochhar, M., Pratt, E. B., et al. (2006a). Kir6.2 mutations associated with neonatal diabetes reduce expression of ATP-Sensitive K+ channels: implications in disease mechanism and sulfonylurea therapy. Diabetes 55, 1738-1746. doi: 10.2337/db05-1571.
61. Lin, Y. W., Macmullen, C., Ganguly, A., Stanley, C. A., and Shyng, S. L. (2006b). A novel KCNJ11 mutation associated with congenital hyperinsulinism reduces the intrinsic open probability of beta-cell ATP-sensitive potassium channels. J. Biol. Chem. 281, 3006-3012. doi: 10.1074/jbc.M511875200.
62. Lin, C. W., Yan, F., Shimamura, S., Barg, S., and Shyng, S. L. (2005). Membrane phosphoinositides control insulin secretion through their effects on ATP-sensitive K+ channel activity. Diabetes 54, 2852-2858. doi: 10.2337/diabetes.54.10.2852.
63. Lin, Y. W., Bushman, J. D., Yan, F. F., Haidar, S., Macmullen, C., Ganguly, A., et al. (2008). Destabilization of ATP-sensitive potassium channel activity by novel KCNJ11 mutations identified in congenital hyperinsulinism. J. Biol. Chem. 283, 9146-9156. doi: 10.1074/jbc.M708798200.
64. Lin, Y. W., Li, A., Grasso, V., Battaglia, D., Crino, A., Colombo, C., et al. (2013). Functional characterization of a novel KCNJ11 in frame mutation-deletion associated with infancy-onset diabetes and a mild form of intermediate DEND: a battle between K(ATP) gain of channel activity and loss of channel expression. PLoS ONE 8:e63758. doi: 10.1371/journal.pone.0063758.
65. Loo, T. W., and Clarke, D. M. (1997). Correction of defective protein kinesis of human P-glycoprotein mutants by substrates and modulators. J. Biol. Chem. 272, 709-712. doi: 10.1074/jbc.272.2.709.
66. Loo, T. W., and Clarke, D. M. (1998). Superfolding of the partially unfolded core-glycosylated intermediate of human P-glycoprotein into the mature enzyme is promoted by substrate-induced transmembrane domain interactions. J. Biol. Chem. 273, 14671-14674. doi: 10.1074/jbc.273.24.14671.
67. Lopatin, A. N., Makhina, E. N., and Nichols, C. G. (1994). Potassium channel block by cytoplasmic polyamines as the mechanism of intrinsic rectification. Nature 372, 366-369. doi: 10.1038/372366a0.
68. Loussouarn, G., Phillips, L. R., Masia, R., Rose, T., and Nichols, C. G. (2001). Flexibility of the Kir6.2 inward rectifier K(+) channel pore. Proc. Natl. Acad. Sci. U.S.A. 98, 4227-4232. doi: 10.1073/pnas.061452698.
69. Macmullen, C. M., Zhou, Q., Snider, K. E., Tewson, P. H., Becker, S. A., Aziz, A. R., et al. (2011). Diazoxide-unresponsive congenital hyperinsulinism in children with dominant mutations of the beta-cell sulfonylurea receptor SUR1. Diabetes 60, 1797-1804. doi: 10.2337/db10-1631.
70. Manley, P. W., Quast, U., Andres, H., and Bray, K. (1993). Synthesis of and radioligand binding studies with a tritiated pinacidil analogue: receptor interactions of structurally different classes of potassium channel openers and blockers. J. Med. Chem. 36, 2004-2010. doi: 10.1021/jm00066a009.
71. Manna, P. T., Smith, A. J., Taneja, T. K., Howell, G. J., Lippiat, J. D., and Sivaprasadarao, A. (2010). Constitutive endocytic recycling and protein kinase C-mediated lysosomal degradation control K(ATP) channel surface density. J. Biol. Chem. 285, 5963-5973. doi: 10.1074/jbc.M109.066902.
72. Markworth, E., Schwanstecher, C., and Schwanstecher, M. (2000). ATP4-mediates closure of pancreatic beta-cell ATP-sensitive potassium channels by interaction with 1 of 4 identical sites. Diabetes 49, 1413-1418. doi: 10.2337/diabetes.49.9.1413.
73. Marthinet, E., Bloc, A., Oka, Y., Tanizawa, Y., Wehrle-Haller, B., Bancila, V., et al. (2005). Severe congenital hyperinsulinism caused by a mutation in the Kir6.2 subunit of the adenosine triphosphate-sensitive potassium channel impairing trafficking and function. J. Clin. Endocrinol. Metab. 90, 5401-5406. doi: 10.1210/jc.2005-0202.
74. Masia, R., Enkvetchakul, D., and Nichols, C. G. (2005). Differential nucleotide regulation of KATP channels by SUR1 and SUR2A. J. Mol. Cell. Cardiol. 39, 491-501. doi: 10.1016/j.yjmcc.2005.03.009.
75. Masia, R., and Nichols, C. G. (2008). Functional clustering of mutations in the dimer interface of the nucleotide binding folds of the sulfonylurea receptor. J. Biol. Chem. 283, 30322-30329. doi: 10.1074/jbc.M804318200.
76. Matsuo, M., Kimura, Y., and Ueda, K. (2005). KATP channel interaction with adenine nucleotides. J. Mol. Cell. Cardiol. 38, 907-916. doi: 10.1016/j.yjmcc.2004.11.021.
77. Mikhailov, M. V., Campbell, J. D., De Wet, H., Shimomura, K., Zadek, B., Collins, R. F., et al. (2005). 3-D structural and functional characterization of the purified KATP channel complex Kir6.2-SUR1. EMBO J. 24, 4166-4175. doi: 10.1038/sj.emboj.7600877.
78. Moreau, C., Jacquet, H., Prost, A. L., D'hahan, N., and Vivaudou, M. (2000). The molecular basis of the specificity of action of K(ATP) channel openers. EMBO J. 19, 6644-6651. doi: 10.1093/emboj/19.24.6644.
79. Morello, J. P., Salahpour, A., Laperriere, A., Bernier, V., Arthus, M. F., Lonergan, M., et al. (2000). Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J. Clin. Invest. 105, 887-895. doi: 10.1172/JCI8688.
80. Muzyamba, M., Farzaneh, T., Behe, P., Thomas, A., Christesen, H. B., Brusgaard, K., et al. (2007). Complex ABCC8 DNA variations in congenital hyperinsulinism: lessons from functional studies. Clin. Endocrinol. (Oxf). 67, 115-124. doi: 10.1111/j.1365-2265.2007.02847.x.
81. Nestorowicz, A., Glaser, B., Wilson, B. A., Shyng, S. L., Nichols, C. G., Stanley, C. A., et al. (1998). Genetic heterogeneity in familial hyperinsulinism. Hum. Mol. Genet. 7, 1119-1128. doi: 10.1093/hmg/7.7.1119.
82. Nestorowicz, A., Inagaki, N., Gonoi, T., Schoor, K. P., Wilson, B. A., Glaser, B., et al. (1997). A nonsense mutation in the inward rectifier potassium channel gene, Kir6.2, is associated with familial hyperinsulinism. Diabetes 46, 1743-1748. doi: 10.2337/diab.46.11.1743.
83. Nichols, C. G. (2006). KATP channels as molecular sensors of cellular metabolism. Nature 440, 470-476. doi: 10.1038/nature04711.
84. Nichols, C. G., and Lopatin, A. N. (1997). Inward rectifier potassium channels. Annu. Rev. Physiol. 59, 171-191. doi: 10.1146/annurev.physiol.59.1.171.
85. Nichols, C. G., Makhina, E. N., Pearson, W. L., Sha, Q., and Lopatin, A. N. (1996a). Inward rectification and implications for cardiac excitability. Circ. Res. 78, 1-7. doi: 10.1161/01.RES.78.1.1.
86. Nichols, C. G., Shyng, S. L., Nestorowicz, A., Glaser, B., Clement, J. P. T., Gonzalez, G., et al. (1996b). Adenosine diphosphate as an intracellular regulator of insulin secretion. Science 272, 1785-1787. doi: 10.1126/science.272.5269.1785.
87. Nilsson, T., Schultz, V., Berggren, P. O., Corkey, B. E., and Tornheim, K. (1996). Temporal patterns of changes in ATP/ADP ratio, glucose 6-phosphate and cytoplasmic free Ca2+ in glucose-stimulated pancreatic beta-cells. Biochem. J. 314(pt 1), 91-94.
88. Noma, A. (1983). ATP-regulated K+ channels in cardiac muscle. Nature 305, 147-148. doi: 10.1038/305147a0.
89. Ortiz, D., Gossack, L., Quast, U., and Bryan, J. (2013). Reinterpreting the action of ATP analogs on K(ATP) channels. J. Biol. Chem. 288, 18894-18902. doi: 10.1074/jbc.M113.476887.
90. Ortiz, D., Voyvodic, P., Gossack, L., Quast, U., and Bryan, J. (2012). Two neonatal diabetes mutations on transmembrane helix 15 of SUR1 increase affinity for ATP and ADP at nucleotide binding domain 2. J. Biol. Chem. 287, 17985-17995. doi: 10.1074/jbc.M112.349019.
91. Partridge, C. J., Beech, D. J., and Sivaprasadarao, A. (2001). Identification and pharmacological correction of a membrane trafficking defect associated with a mutation in the sulfonylurea receptor causing familial hyperinsulinism. J. Biol. Chem. 276, 35947-35952. doi: 10.1074/jbc.M104762200.
92. Pedemonte, N., Lukacs, G. L., Du, K., Caci, E., Zegarra-Moran, O., Galietta, L. J., et al. (2005). Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening. J. Clin. Invest. 115, 2564-2571. doi: 10.1172/JCI24898.
93. Powell, P. D., Bellanne-Chantelot, C., Flanagan, S. E., Ellard, S., Rooman, R., Hussain, K., et al. (2011). In vitro recovery of ATP-sensitive potassium channels in beta-cells from patients with congenital hyperinsulinism of infancy. Diabetes 60, 1223-1228. doi: 10.2337/db10-1443.
94. Powers, E. T., Morimoto, R. I., Dillin, A., Kelly, J. W., and Balch, W. E. (2009). Biological and chemical approaches to diseases of proteostasis deficiency. Annu. Rev. Biochem. 78, 959-991. doi: 10.1146/annurev.biochem.052308.114844.
95. Pratt, E. B., Tewson, P., Bruederle, C. E., Skach, W. R., and Shyng, S. L. (2011). N-terminal transmembrane domain of SUR1 controls gating of Kir6.2 by modulating channel sensitivity to PIP2. J. Gen. Physiol. 137, 299-314. doi: 10.1085/jgp.201010557.
96. Pratt, E. B., Yan, F. F., Gay, J. W., Stanley, C. A., and Shyng, S. L. (2009). Sulfonylurea receptor 1 mutations that cause opposite insulin secretion defects with chemical chaperone exposure. J. Biol. Chem. 284, 7951-7959. doi: 10.1074/jbc.M807012200.
97. Proks, P., Antcliff, J. F., Lippiat, J., Gloyn, A. L., Hattersley, A. T., and Ashcroft, F. M. (2004). Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features. Proc. Natl. Acad. Sci. U.S.A. 101, 17539-17544. doi: 10.1073/pnas.0404756101.
98. Proks, P., Arnold, A. L., Bruining, J., Girard, C., Flanagan, S. E., Larkin, B., et al. (2006). A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes. Hum. Mol. Genet. 15, 1793-1800. doi: 10.1093/hmg/ddl101.
99. Proks, P., Girard, C., Haider, S., Gloyn, A. L., Hattersley, A. T., Sansom, M. S., et al. (2005). A gating mutation at the internal mouth of the Kir6.2 pore is associated with DEND syndrome. EMBO Rep. 6, 470-475. doi: 10.1038/sj.embor.7400393.
100. Quast, U., Stephan, D., Bieger, S., and Russ, U. (2004). The impact of ATP-sensitive K+ channel subtype selectivity of insulin secretagogues for the coronary vasculature and the myocardium. Diabetes 53(Suppl. 3), S156-S164. doi: 10.2337/diabetes.53.suppl_3.S156.
101. Reimann, F., Tucker, S. J., Proks, P., and Ashcroft, F. M. (1999). Involvement of the n-terminus of Kir6.2 in coupling to the sulphonylurea receptor. J. Physiol. 518, 325-336. doi: 10.1111/j.1469-7793.1999.0325p.x.
102. Riedel, M. J., and Light, P. E. (2005). Saturated and cis/trans unsaturated acyl CoA esters differentially regulate wild-type and polymorphic beta-cell ATP-sensitive K+ channels. Diabetes 54, 2070-2079. doi: 10.2337/diabetes.54.7.2070.
103. Riordan, J. R., Rommens, J. M., Kerem, B., Alon, N., Rozmahel, R., Grzelczak, Z., et al. (1989). Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245, 1066-1073. doi: 10.1126/science.2475911.
104. Rowe, S. M., and Verkman, A. S. (2013). Cystic fibrosis transmembrane regulator correctors and potentiators. Cold Spring Harb. Perspect. Med. 3:a009761. doi: 10.1101/cshperspect.a009761.
105. Sampson, H. M., Lam, H., Chen, P. C., Zhang, D., Mottillo, C., Mirza, M., et al. (2013). Compounds that correct F508del-CFTR trafficking can also correct other protein trafficking diseases: an in vitro study using cell lines. Orphanet J. Rare Dis. 8, 11. doi: 10.1186/1750-1172-8-11.
106. Sarkar, S., Perlstein, E. O., Imarisio, S., Pineau, S., Cordenier, A., Maglathlin, R. L., et al. (2007). Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. Nat. Chem. Biol. 3, 331-338. doi: 10.1038/nchembio883.
107. Schulze, D., Rapedius, M., Krauter, T., and Baukrowitz, T. (2003). LC-CoA esters and PIPs modulate ATP inhibition of KATP channels by the same mechanism. J. Physiol. 552, 357-367. doi: 10.1113/jphysiol.2003.047035.
108. Schwanstecher, M., Loser, S., Chudziak, F., Bachmann, C., and Panten, U. (1994). Photoaffinity labeling of the cerebral sulfonylurea receptor using a novel radioiodinated azidoglibenclamide analogue. J. Neurochem. 63, 698-708. doi: 10.1046/j.1471-4159.1994.63020698.x.
109. Schwappach, B., Zerangue, N., Jan, Y. N., and Jan, L. Y. (2000). Molecular basis for K(ATP) assembly: transmembrane interactions mediate association of a K+ channel with an ABC transporter. Neuron 26, 155-167. doi: 10.1016/S0896-6273(00)81146-0.
110. Schwartz, T. B., and Meinert, C. L. (2004). The UGDP controversy: thirty-four years of contentious ambiguity laid to rest. Perspect. Biol. Med. 47, 564-574. doi: 10.1353/pbm.2004.0071.
111. Sharma, N., Crane, A., Clement, J. P. T., Gonzalez, G., Babenko, A. P., Bryan, J., et al. (1999). The C terminus of SUR1 is required for trafficking of KATP channels. J. Biol. Chem. 274, 20628-20632. doi: 10.1074/jbc.274.29.20628.
112. Shyng, S. L., Cukras, C. A., Harwood, J., and Nichols, C. G. (2000). Structural determinants of PIP(2) regulation of inward rectifier K(ATP) channels. J. Gen. Physiol. 116, 599-608. doi: 10.1085/jgp.116.5.599.
113. Shyng, S. L., Ferrigni, T., Shepard, J. B., Nestorowicz, A., Glaser, B., Permutt, M. A., et al. (1998). Functional analyses of novel mutations in the sulfonylurea receptor 1 associated with persistent hyperinsulinemic hypoglycemia of infancy. Diabetes 47, 1145-1151. doi: 10.2337/diabetes.47.7.1145.
114. Shyng, S., and Nichols, C. G. (1997). Octameric stoichiometry of the KATP channel complex. J. Gen. Physiol. 110, 655-664. doi: 10.1085/jgp.110.6.655.
115. Shyng, S. L., and Nichols, C. G. (1998). Membrane phospholipid control of nucleotide sensitivity of KATP channels. Science 282, 1138-1141. doi: 10.1126/science.282.5391.1138.
116. Snider, K. E., Becker, S., Boyajian, L., Shyng, S. L., Macmullen, C., Hughes, N., et al. (2013). Genotype and phenotype correlations in 417 children with congenital hyperinsulinism. J. Clin. Endocrinol. Metab. 98, E355-E363. doi: 10.1210/jc.2012-2169.
117. Stanley, C. A. (1997). Hyperinsulinism in infants and children. Pediatr. Clin. North Am. 44, 363-374. doi: 10.1016/S0031-3955(05)70481-8.
118. Taneja, T. K., Mankouri, J., Karnik, R., Kannan, S., Smith, A. J., Munsey, T., et al. (2009). Sar1-GTPase-dependent ER exit of KATP channels revealed by a mutation causing congenital hyperinsulinism. Hum. Mol. Genet. 18, 2400-2413. doi: 10.1093/hmg/ddp179.
119. Tarasov, A., Dusonchet, J., and Ashcroft, F. (2004). Metabolic regulation of the pancreatic beta-cell ATP-sensitive K+ channel: a pas de deux. Diabetes 53(Suppl. 3), S113-S122. doi: 10.2337/diabetes.53.suppl_3.S113.
120. Taschenberger, G., Mougey, A., Shen, S., Lester, L. B., Lafranchi, S., and Shyng, S. L. (2002). Identification of a familial hyperinsulinism-causing mutation in the sulfonylurea receptor 1 that prevents normal trafficking and function of KATP channels. J. Biol. Chem. 277, 17139-17146. doi: 10.1074/jbc.M200363200.
121. Tornovsky, S., Crane, A., Cosgrove, K. E., Hussain, K., Lavie, J., Heyman, M., et al. (2004). Hyperinsulinism of infancy: novel ABCC8 and KCNJ11 mutations and evidence for additional locus heterogeneity. J. Clin. Endocrinol. Metab. 89, 6224-6234. doi: 10.1210/jc.2004-1233.
122. Tucker, S. J., Gribble, F. M., Zhao, C., Trapp, S., and Ashcroft, F. M. (1997). Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor. Nature 387, 179-183. doi: 10.1038/387179a0.
123. Tusnady, G. E., Bakos, E., Varadi, A., and Sarkadi, B. (1997). Membrane topology distinguishes a subfamily of the ATP-binding cassette (ABC) transporters. FEBS Lett. 402, 1-3. doi: 10.1016/S0014-5793(96)01478-0.
124. Vila-Carriles, W. H., Zhao, G., and Bryan, J. (2007). Defining a binding pocket for sulfonylureas in ATP-sensitive potassium channels. FASEB J. 21, 18-25. doi: 10.1096/fj.06-6730hyp.
125. Wang, F., Olson, E. M., and Shyng, S. L. (2012). Role of Derlin-1 protein in proteostasis regulation of ATP-sensitive potassium channels. J. Biol. Chem. 287, 10482-10493. doi: 10.1074/jbc.M111.312223.
126. Ward, C. L., and Kopito, R. R. (1994). Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins. J. Biol. Chem. 269, 25710-25718.
127. Ward, C. L., Omura, S., and Kopito, R. R. (1995). Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 83, 121-127. doi: 10.1016/0092-8674(95)90240-6.
128. Yan, F., Lin, C. W., Weisiger, E., Cartier, E. A., Taschenberger, G., and Shyng, S. L. (2004). Sulfonylureas correct trafficking defects of ATP-sensitive potassium channels caused by mutations in the sulfonylurea receptor. J. Biol. Chem. 279, 11096-11105. doi: 10.1074/jbc.M312810200.
129. Yan, F. F., Casey, J., and Shyng, S. L. (2006). Sulfonylureas correct trafficking defects of disease-causing ATP-sensitive potassium channels by binding to the channel complex. J. Biol. Chem. 281, 33403-33413. doi: 10.1074/jbc.M605195200.
130. Yan, F. F., Lin, C. W., Cartier, E. A., and Shyng, S. L. (2005). Role of ubiquitin-proteasome degradation pathway in biogenesis efficiency of {beta}-cell ATP-sensitive potassium channels. Am. J. Physiol. Cell Physiol. 289, C1351-C1359. doi: 10.1152/ajpcell.00240.2005.
131. Yan, F. F., Lin, Y. W., Macmullen, C., Ganguly, A., Stanley, C. A., and Shyng, S. L. (2007). Congenital hyperinsulinism associated ABCC8 mutations that cause defective trafficking of ATP-sensitive K+ channels: identification and rescue. Diabetes 56, 2339-2348. doi: 10.2337/db07-0150.
132. Yan, F. F., Pratt, E. B., Chen, P. C., Wang, F., Skach, W. R., David, L. L., et al. (2010). Role of Hsp90 in biogenesis of the beta-cell ATP-sensitive potassium channel complex. Mol. Biol. Cell 21, 1945-1954. doi: 10.1091/mbc.E10-02-0116.
133. Yang, K., Fang, K., Fromondi, L., and Chan, K. W. (2005). Low temperature completely rescues the function of two misfolded K ATP channel disease-mutants. FEBS Lett. 579, 4113-4118. doi: 10.1016/j.febslet.2005.06.039.
134. Yang, S. N., Wenna, N. D., Yu, J., Yang, G., Qiu, H., Yu, L., et al. (2007). Glucose recruits K(ATP) channels via non-insulin-containing dense-core granules. Cell Metab. 6, 217-228. doi: 10.1016/j.cmet.2007.08.002.
135. Ye, Y., Shibata, Y., Yun, C., Ron, D., and Rapoport, T. A. (2004). A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature 429, 841-847. doi: 10.1038/nature02656.
136. Yorifuji, T., Nagashima, K., Kurokawa, K., Kawai, M., Oishi, M., Akazawa, Y., et al. (2005). The C42R mutation in the Kir6.2 (KCNJ11) gene as a cause of transient neonatal diabetes, childhood diabetes, or later-onset, apparently type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 90, 3174-3178. doi: 10.1210/jc.2005-0096.
137. Yuan, H., Michelsen, K., and Schwappach, B. (2003). 14-3-3 dimers probe the assembly status of multimeric membrane proteins. Curr. Biol. 13, 638-646. doi: 10.1016/S0960-9822(03)00208-2.
138. Zerangue, N., Schwappach, B., Jan, Y. N., and Jan, L. Y. (1999). A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane K(ATP) channels. Neuron 22, 537-548. doi: 10.1016/S0896-6273(00)80708-4.
139. Zhou, Q., Garin, I., Castano, L., Argente, J., Munoz-Calvo, M. T., Perez De Nanclares, G., et al. (2010). Neonatal diabetes caused by mutations in sulfonylurea receptor 1: interplay between expression and Mg-nucleotide gating defects of ATP-sensitive potassium channels. J. Clin. Endocrinol. Metab. 95, E473-E478. doi: 10.1210/jc.2010-1231.
140. Zhou, Q., Pratt, E. B., and Shyng, S. L. (2013). Engineered Kir6.2 mutations that correct the trafficking defect of KATP channels caused by specific SUR1 mutations. Channels (Austin) 7, 313-317. doi: 10.4161/chan.25003.
141. Zhou, Z., Gong, Q., and January, C. T. (1999). Correction of defective protein trafficking of a mutant HERG potassium channel in human long QT syndrome. Pharmacological and temperature effects. J. Biol. Chem. 274, 31123-31126. doi: 10.1074/jbc.274.44.31123.
142. + conductance. Neuron 31, 233-245. doi: 10.1016/S0896-6273(01)00356-7.